Actively Recruiting
Duobrii in Combination With Biologics
Led by Psoriasis Treatment Center of Central New Jersey · Updated on 2020-04-30
25
Participants Needed
1
Research Sites
46 weeks
Total Duration
On this page
Sponsors
P
Psoriasis Treatment Center of Central New Jersey
Lead Sponsor
O
Ortho Dermatologics
Collaborating Sponsor
AI-Summary
What this Trial Is About
12 weeks DUOBRII to patients with 2%-10% BSA who are receiving biologic therapy for at least 24 weeks
CONDITIONS
Official Title
Duobrii in Combination With Biologics
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female adult 63 18 years of age
- Diagnosis of chronic plaque-type psoriasis
- Psoriasis affecting 2%-10% body surface area
- Receiving biologic therapy for at least 24 weeks
- Able and willing to give written informed consent prior to any study procedures
You will not qualify if you...
- Psoriasis affecting c2% or more than 10% body surface area
- Not receiving biologic therapy or biologic therapy for less than 24 weeks
- Received any topical antipsoriatic treatment within 14 days before baseline visit
- Previously used DUOBRII
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Psoriasis Treatment Center of Central New Jersey
East Windsor, New Jersey, United States, 08520
Actively Recruiting
Research Team
J
Jerry Bagel, MD
CONTACT
E
Elise Nelson
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here